The Food and Drug Administration (FDA) has submitted a proposed "Cannabidiol (CBD) Products Compliance and Enforcement Policy" to the White House for review. The proposal may address missing cannabinoid lists mandated by Congress, facilitate federal health insurance coverage for CBD under Medicare, or establish long-awaited regulations for marketing CBD in the food supply.

FDA Submits Updated Cannabis Enforcement Policy for Review

Mar 16, 2026

Source:

Kyle Jaeger

Marijuana Moment

Big news for the CBD community: the FDA has officially sent a new "Cannabidiol Products Compliance and Enforcement Policy" to the White House for review. While the specific text hasn't been released yet, this move is a major signal that federal regulators are finally getting serious about CBD. It could be anything from a response to missed deadlines for listing cannabinoids to a step toward allowing Medicare to cover CBD for patients.

This matters because, for too long, CBD has existed in a confusing regulatory "gray zone." If the FDA establishes clear rules, it could lead to better quality control, more reliable labeling, and eventually, easier access through health insurance. For regular users, this is a positive step toward legitimacy. It suggests that instead of just looking the other way, the government is looking for a path to integrate these products into the mainstream. Clearer federal guidelines mean a safer, more stable market for the shops we love and the products we rely on.

Recent Reviews

Mountain High Black Cherry: Elevating the Low-Dose Category

Mountain High is expanding its lineup with Black Cherry, a new release that continues the brand’s tradition of thoughtful flavor, balanced effects, and an easygoing drinking experience suitable for almost any occasion. Available through the brand’s new website and at hundreds of retailers across Virginia, Black Cherry arrives with high expectations — and meets them gracefully...

Fade Co.'s Live Concentrates Lineup at Story Mechanicsville: A Connoisseur’s Tour

Fade Co. continues to demonstrate why it remains one of Maryland’s most consistent and interesting concentrate producers. Currently in stock at Story Dispensary in Mechanicsville, their latest live sugar and live badder lineup offers a diverse range of profiles — from bold, gassy hybrids to bright, fruit-forward sativas and soothing indicas.

Koosh The Magic Dragon | Byline | Virginia Homegrown

Koosh The Magic Dragon (KTMD) feels like the cannabis world’s best-kept secret — a strain that hasn’t yet gone mainstream but already has that quiet “you had to be there” reputation. Bred by Byline, this relatively new genetic is still circulating mostly through craft grower networks rather than dominating every dispensary shelf. That limited exposure gives it a charming underground mystique, like a dragon that only reveals itself to those worthy of its smoke...

2 3 4 5

Menu